Evotec Publicly Traded Corporation
Evotec is a drug discovery alliance and development partnership rapidly progressing innovative product approaches with pharmaceutical and biotechnology companies, academics, patient advocacy groups, and venture capitalists. Drug discovery solutions are provided in the form of fee-for-service work, integrated drug discovery alliances, development partnerships, licencing of innovative drug candidates, and consulting arrangements.
Investors
Founded Date:
1993-01-01
Last Funding Date:
2025-05-07
Total Funding:
746736691
Headquarters:
Hamburg,Hamburg,Germany,Europe
Employee Number:
1001-5000
Funding Stage:
IPO
Funding Total Value:
746736691
Last Funding Total Usd:
2500000
Last Funding Total Currency:
USD
Last Funding Total Value:
2500000
Founders:
Charles Weissmann,Freimut Leidenberger,Heinrich M. Schulte,Karsten Henco,Manfred Eigen,Rudolf Rigler,Ulrich Aldag
Phone Number:
+ 49 (0)40 56081-222
Stock Symbol:
EVT
City:
Hamburg
Region:
Hamburg
Country:
Germany











.png)





